ApoE gene variants thus modulate lipoprotein particle clearance rate and as such, LDL/CH levels, with some alleles conferring a higher risk for dyslipidemia and states of vascular inflammation such as coronary artery disease (CAD) [163]. This evidence concerns the gene APOE and coronary artery disorder.